*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
C511 - Malignant neoplasm of labium minus - as a primary diagnosis code | C511 - Malignant neoplasm of labium minus - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 3.53 | |
Readmission Rate (%) | 16.2 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 747: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 746: VAGINA, CERVIX AND VULVA PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 5,216 | |
Total Hospitalizations with ICD C511 - Malignant neoplasm of labium minus | 35 | |
DRG Share of Total Hospitalizations | 0.02 | |
% of Total ICD C511 - Malignant neoplasm of labium minus in DRG | 35.35 | |
Avg LOS at DRG | 1.8 | |
Avg LOS with ICD C511 - Malignant neoplasm of labium minus | 1.74 | |
Readmission Rate at DRG | 6.99 | |
Readmission Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
Unplanned Readmission Rate at DRG | 4.34 | |
Unplanned Readmission Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
Total Medicare payments at DRG | $29,263,906 | |
Total Medicare payments with ICD C511 - Malignant neoplasm of labium minus | $214,760 | |
Total Medicare payment per Day at DRG | $3,119 | |
Total Medicare payment per Day with ICD C511 - Malignant neoplasm of labium minus | $3,521 | |
Total Medicare payment per Hospitalization at DRG | $5,610 | |
Total Medicare payment per Hospitalization with ICD C511 - Malignant neoplasm of labium minus | $6,136 | |
Total Medicare Charges at DRG | $184,533,401 | |
Total Medicare Charges with ICD C511 - Malignant neoplasm of labium minus | $1,176,212 | |
Avg Charges at DRG | $35,378 | |
Avg Charges with ICD C511 - Malignant neoplasm of labium minus | $33,606 | |
Mortality Rate at DRG | NA | |
Mortality Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
SNF Discharge Rate at DRG | 4.47 | |
SNF Discharge Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
Home Discharge Rate at DRG | 83.09 | |
Home Discharge Rate with ICD C511 - Malignant neoplasm of labium minus | 60.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 747: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 746: VAGINA, CERVIX AND VULVA PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 5,216 | |
Total Hospitalizations with ICD C511 - Malignant neoplasm of labium minus | 47 | |
DRG Share of Total Hospitalizations | 0.02 | |
% of Total ICD C511 - Malignant neoplasm of labium minus in DRG | 31.13 | |
Avg LOS at DRG | 1.8 | |
Avg LOS with ICD C511 - Malignant neoplasm of labium minus | 1.96 | |
Readmission Rate at DRG | 6.99 | |
Readmission Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
Unplanned Readmission Rate at DRG | 4.34 | |
Unplanned Readmission Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
Total Medicare payments at DRG | $29,263,906 | |
Total Medicare payments with ICD C511 - Malignant neoplasm of labium minus | $283,357 | |
Total Medicare payment per Day at DRG | $3,119 | |
Total Medicare payment per Day with ICD C511 - Malignant neoplasm of labium minus | $3,080 | |
Total Medicare payment per Hospitalization at DRG | $5,610 | |
Total Medicare payment per Hospitalization with ICD C511 - Malignant neoplasm of labium minus | $6,029 | |
Total Medicare Charges at DRG | $184,533,401 | |
Total Medicare Charges with ICD C511 - Malignant neoplasm of labium minus | $1,531,815 | |
Avg Charges at DRG | $35,378 | |
Avg Charges with ICD C511 - Malignant neoplasm of labium minus | $32,592 | |
Mortality Rate at DRG | NA | |
Mortality Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
SNF Discharge Rate at DRG | 4.47 | |
SNF Discharge Rate with ICD C511 - Malignant neoplasm of labium minus | NA | |
Home Discharge Rate at DRG | 83.09 | |
Home Discharge Rate with ICD C511 - Malignant neoplasm of labium minus | 63.83 |